Taiwan Sugar Corporation appeared to be the Corporate Investor, which was created in 1946.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2009.
Among the various public portfolio startups of the fund, we may underline TaiGen Biotechnology Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Pharmaceutical.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Taiwan Sugar Corporation, startups are often financed by YFY Inc., Shin Kong Life Insurance, Major Series A. The meaningful sponsors for the fund in investment in the same round are YFY Inc., YFY Biotech Management Company, National Development Fund of Taiwan Government.
Related Funds
| Fund Name | Location |
| Archer Capital | Australia, New South Wales, Sydney |
| Byte Ventures | Boston, Massachusetts, United States |
| DHC Software | Beijing, Beijing, China |
| East Seattle Partners | - |
| Fluid Vehicle Owners | - |
| Fuji Electronics | Japan, Tokyo |
| Huarui Tianxin Touzi | Beijing, China, Haidian |
| Kukula Capital | Lusaka, Lusaka, Zambia |
| Mindshift Capital | Dubai, United Arab Emirates |
| OC Funds Management | - |
| Propel Capital | New York, New York, United States |
| Prototron | Estonia, Harjumaa, Tallinn |
| Qina Chuangtou | China, Jiangsu, Suzhou |
| Rio Ventures | - |
| Rockies Venture Club | Colorado, Denver, United States |
| STIHL Digital | Baden-Wurttemberg, Germany, Waiblingen |
| TI Platform Management | California, San Francisco, United States |
| Woodward Angels | Detroit, Michigan, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan |
